Association between PARK16 and Parkinson's disease: A meta-analysis

Area of Science:

• Genetics
• Neuroscience
• Epidemiology

Background:

• Several case-control studies have investigated the association between PARK16 locus polymorphisms (rs947211 and rs1572913) and Parkinson's disease (PD).
• Previous findings have been inconsistent, necessitating a more robust analysis to clarify these associations.

Purpose of the Study:

• To conduct a comprehensive meta-analysis evaluating the relationship between rs947211 and rs1572913 polymorphisms and Parkinson's disease risk.
• To synthesize evidence from multiple studies to provide a clearer understanding of the genetic contribution to PD susceptibility.

Main Methods:

• A systematic literature search was performed across seven major databases (PubMed, Google Scholar, EMBASE, Web of Science, CNKI, VIP, Wanfang).
• Eligible studies involving case-control data were included, with a total of 15 studies comprising 6637 cases and 6774 controls.
• Statistical analysis using odds ratios (ORs) and 95% confidence intervals (CIs) was employed to assess the associations.

Main Results:

• The meta-analysis revealed that rs947211 variants are associated with a decreased risk of PD in the overall population.
• Stratified analyses indicated a significant reduction in PD risk for rs947211 variants in Northeast Asian populations, and a slight decrease in Southeast Asian and Caucasian populations.
• The rs1572913 polymorphism was also found to be associated with a decreased risk of PD.

Conclusions:

• The rs947211 variants (A allele, AG, and GG genotypes) may confer a protective effect against Parkinson's disease, especially in Northeast Asian populations.
• The rs1572913 variants (T allele, TC, and TT genotypes) also contribute to a reduced risk of developing Parkinson's disease.
• These findings highlight the potential role of PARK16 locus polymorphisms in PD pathogenesis and susceptibility.